11 Results for "

Safinamide acid

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "Safinamide acid" in MCE Product Catalog:

Cat. No.: HY-W717548
CAS No.: 1160513-60-9
Target:  

Drug Metabolite

Research Areas:  

Others

Safinamide acid (Compound Imp-E) is the metabolite of Safinamide (HY-70057). Safinamide acid can be formed by hydrolysis of Safinamide intermediate under alkaline or acidic conditions. Safinamide acid is utilized to monitor process-related impurities and degradation products in safinamide samples .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-70057
CAS No.: 133865-89-1
Synonyms: FCE 26743; EMD 1195686
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

Safinamide is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor (IC50=0.098 μM) over MAO-A (IC50=580 μM) . Safinamide also blocks sodium channels and modulates glutamate (Glu) release, showing a greater affinity at depolarized (IC50=8 μM) than at resting (IC50=262 μM) potentials. Safinamide has neuroprotective and neurorescuing effects and can be used for the study of parkinson disease, ischemia stroke etc.al .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-70057A
CAS No.: 202825-46-5
Synonyms: FCE 26743 mesylate; EMD 1195686 mesylate
Safinamide (FCE 26743; EMD 1195686) mesylate is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor (IC50=0.098 μM) over MAO-A (IC50=580 nM) . Safinamide mesylate also blocks sodium channels and modulates glutamate (Glu) release, showing a greater affinity at depolarized (IC50=8 μM) than at resting (IC50=262 μM) potentials. Safinamide mesylate has neuroprotective and neurorescuing effects and can be used for the study of parkinson disease, ischemia stroke et.al .
loading...
    loading...
Cat. No.: HY-14203
CAS No.: 174756-44-6
Purity:  99.89%
Synonyms: FCE 28073; (R)-EMD 1195686
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

(R)-Safinamide (FCE 28073) is the enantiomer of Safinamide (HY-70057). (R)-Safinamide is an orally active, alanine-derived monoamine oxidase inhibitor with an IC50 of 1.77 μM for rat MAO-B and an IC50 of 50 μM for rat MAO-A. (R)-Safinamide regulates the activity of monoamine oxidase isoforms in brain homogenates. (R)-Safinamide is used in epilepsy research .
loading...
    loading...
Cat. No.: HY-70057S1
CAS No.: 2748522-33-8
Synonyms: FCE 26743-d4-1; EMD 1195686-d4-1
Safinamide-d4-1 is deuterium labeled Safinamide. Safinamide is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor (IC50=0.098 μM) over MAO-A (IC50=580 μM) . Safinamide also blocks sodium channels and modulates glutamate (Glu) release, showing a greater affinity at depolarized (IC50=8?μM) than at resting (IC50=262?μM) potentials. Safinamide has neuroprotective and neurorescuing effects and can be used for the study of parkinson disease, ischemia stroke etc.al .
loading...
    loading...
Cat. No.: HY-150531S
CAS No.: 1147299-71-5
Safinamide d3 is the deuterium labeled Safinamide .
loading...
    loading...
Cat. No.: HY-70057R
CAS No.: 133865-89-1
Synonyms: FCE 26743 (Standard); EMD 1195686 (Standard)
Safinamide (Standard) is the analytical standard of Safinamide. This product is intended for research and analytical applications. Safinamide is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor (IC50=0.098 µM) over MAO-A (IC50=580 µM) . Safinamide also blocks sodium channels and modulates glutamate (Glu) release, showing a greater affinity at depolarized (IC50=8 µM) than at resting (IC50=262 µM) potentials. Safinamide has neuroprotective and neurorescuing effects and can be used for the study of parkinson disease, ischemia stroke etc.al .
loading...
    loading...
Cat. No.: HY-70057S4
Synonyms: FCE 26743-d5; EMD 1195686-d5
Safinamide-d5 (FCE 26743-d5) is deuterium labeled Safinamide. Safinamide is a potent, selective, and reversible monoamine oxidase B (MAO-B) inhibitor (IC50=0.098 μM) over MAO-A (IC50=580 μM) . Safinamide also blocks sodium channels and modulates glutamate (Glu) release, showing a greater affinity at depolarized (IC50=8?μM) than at resting (IC50=262?μM) potentials. Safinamide has neuroprotective and neurorescuing effects and can be used for the study of parkinson disease, ischemia stroke etc.al .
loading...
    loading...
Cat. No.: HY-115987
CAS No.: 2376198-66-0
Target:  

Monoamine Oxidase

Research Areas:  

Neurological Disease

MAO-B-IN-6 is a potent, selective and orally active MAO-B inhibitor with an IC50 of 0.019 µM. MAO-B-IN-6 shows more efficacious than Safinamide in vitro and in vivo. MAO-B-IN-6 has the potential for the research of parkinson's disease (PD) .
loading...
    loading...
Cat. No.: HY-166387S
Safinamide related methyl ester-d4 is the deuterium labeled Safinamide related methyl ester.
loading...
    loading...
Cat. No.: HY-W269511
CAS No.: 405-85-6
Target:  

Drug Derivative

Research Areas:  

Neurological Disease

NW-1689 is a process-related impurity of safinamide mesilate (SAFM). SAFM can be used for the study of Parkinson's disease (PD). It is a highly selective and reversible inhibitor of monoamine oxidase-B (MAO-B) and also blocks sodium channels and N-type calcium channels. These effects of SAFM help reduce the breakdown of dopamine and inhibit the release of glutamate. NW-1689 has a similar chemical structure to SAFM and has some similar pharmacological effects as SAFM, and can be used in Parkinson's disease research .
loading...
    loading...
  • 1